Optometrists in Overland Park, KS Accepting Medicare
104 Optometrists found. Showing 101 - 104
 Rebecca Duffy Nichols, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 7504 Antioch Rd, Overland Park, KS 66204 Phone: 913-341-3100 |
 Aria Vision Care, Llc Optometrist Medicare: Medicare Enrolled Practice Location: 8500 W 110th St Ste 450, Overland Park, KS 66210 Phone: 888-840-3032 |
Dr. Buffie Jane Mock, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 11500 W 119th St, Overland Park, KS 66213 Phone: 913-451-0001 Fax: 913-451-1659 |
Dr. Andrea Dawn Buchbaum, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 10120 W. 119th Street, Overland Park, KS 66213 Phone: 913-339-9090 Fax: 913-339-6417 |
News Archive
Psychiatric illness drugs may protect the brain cells that die in people with Huntington's disease
Researchers at UT Southwestern Medical Center have discovered that drugs commonly used to treat psychiatric illnesses and blood disorders in humans may protect the brain cells that die in people with Huntington's disease, possibly delaying the onset and slowing the progression of the disease.
Baxter enters definitive agreement to acquire Gambro
Baxter International Inc. has entered into a definitive agreement to acquire Gambro AB, a privately held dialysis product company based in Lund, Sweden, for total consideration of 26.5 billion SEK (approximately $4.0 billion USD at current exchange rates).
Positive clinical trial results for Anacor Pharmaceuticals' AN2728 announced
Anacor Pharmaceuticals today announced positive clinical trial results for its lead phosphodiesterase-4 inhibitor, AN2728, a novel topical anti-inflammatory compound derived from Anacor's boron chemistry platform. These results were obtained from a multi-center, Phase 2b, randomized, double-blind, dose-ranging, bilateral trial comparing AN2728 ointment, 0.5% and 2.0%, applied once or twice daily, to vehicle in 145 patients with mild-to-moderate plaque-type psoriasis.
Cell receptor recycling mechanism discovery opens up new class of therapeutic targets
Prof. Manojkumar Puthenveedu of Carnegie Mellon University studies the mechanisms by which membrane trafficking controls and co-ordinates the complex signalling pathways in the brain. Despite the fact that almost all diseases can be traced to a defect in how cells respond to signals, little is known about how signalling pathways are maintained in normal cells and the changes that occur in abnormal conditions.
› Verified 4 days ago
Physical Therapists
Chiropractors
Speech-Language Pathologists
Occupational Therapists
Optometrists
Audiologists
Podiatrists